Enzymatic debridement of burn wound with collagenase in children with partial-thickness burns

Coşkun Ozcan1, Orkan Ergün, Ahmet Celik

  • 1Ege University Faculty of Medicine, Department of Pediatric Surgery, Pediatric Burns Unit, 35100 Bornova, Izmir, Turkey. cozcan@med.ege.edu.tr

Insights

Enzymatic debridement with collagenase clostridiopeptidase A (CCA) offers a shorter hospital stay and reduced need for surgery and transfusions in pediatric partial-thickness burns. CCA is a viable initial treatment for non-infected burn wounds in children.

Area of Science:

  • Pediatric Burn Care
  • Wound Debridement
  • Enzymatic Therapy

Background:

  • Surgical excision is a common method for burn eschar removal.
  • Enzymatic debridement offers a less invasive alternative.
  • Partial-thickness burns require effective and timely wound management.

Purpose of the Study:

  • To compare enzymatic debridement using collagenase clostridiopeptidase A (CCA) with surgical excision in pediatric burn patients.
  • To evaluate the efficacy of CCA in achieving a clean wound bed, need for further surgery, blood transfusions, and hospital stay.
  • To determine if CCA is a suitable initial treatment for partial-thickness pediatric burns.

Main Methods:

  • Retrospective comparison of 78 pediatric patients treated with CCA (groups D and DS) versus 41 patients treated with surgical excision (group S).
  • Patients had partial-thickness burns assessed at admission.
  • Outcomes measured included time to clean wound bed, number of excisions, need for blood transfusion, and hospital length of stay.

Main Results:

  • No significant difference in time to achieve a clean wound bed between groups (mean 7.8 days for CCA vs. 7 days for surgery).
  • Patients treated with CCA (group D) had significantly shorter hospital stays (12.5 days) and fewer required blood transfusions compared to surgical excision.
  • A subset of CCA-treated patients (group DS) required subsequent surgery, but fewer overall excisions than the surgical group.

Conclusions:

  • Collagenase clostridiopeptidase A (CCA) is effective for eschar removal in pediatric partial-thickness burns, leading to shorter hospitalizations.
  • CCA reduces the need for blood transfusions and potentially decreases the overall number of surgical interventions.
  • CCA should be considered a primary treatment option for non-infected partial-thickness pediatric burn wounds.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Phases of Wound Repair01:28

Phases of Wound Repair

Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...